| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials
|
Zhang, Yaru
|
|
|
|
8 |
p. 797-811
|
artikel
|
| 2 |
Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
|
Altman, Roy
|
|
2015
|
|
8 |
p. 859-877
|
artikel
|
| 3 |
Advances in Sepsis Therapy
|
Glück, Thomas
|
|
|
|
8 |
p. 837-859
|
artikel
|
| 4 |
Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer
|
Dolly, Saoirse O.
|
|
2017
|
|
8 |
p. 813-827
|
artikel
|
| 5 |
Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
|
Benitez, Lydia L.
|
|
2019
|
|
8 |
p. 833-853
|
artikel
|
| 6 |
Albiglutide: First Global Approval
|
Poole, Raewyn M.
|
|
2014
|
|
8 |
p. 929-938
|
artikel
|
| 7 |
Androgenetic Alopecia: Therapy Update
|
Devjani, Shivali
|
|
|
|
8 |
p. 701-715
|
artikel
|
| 8 |
A New Paradigm for Achieving a Rapid Antidepressant Response
|
Malhi, Gin S.
|
|
|
|
8 |
p. 755-764
|
artikel
|
| 9 |
Antibiotics and Probiotics for Irritable Bowel Syndrome
|
Goodoory, Vivek C.
|
|
|
|
8 |
p. 687-699
|
artikel
|
| 10 |
Antimicrobial Agents in Orthopaedic Surgery
|
Trampuz, Andrej
|
|
|
|
8 |
p. 1089-1106
|
artikel
|
| 11 |
Apixaban: A Review of its Use for Reducing the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation
|
Keating, Gillian M.
|
|
2013
|
|
8 |
p. 825-843
|
artikel
|
| 12 |
Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
|
Cohen, Hillel P.
|
|
2018
|
|
8 |
p. 853-855
|
artikel
|
| 13 |
Avelumab: First Global Approval
|
Kim, Esther S.
|
|
|
|
8 |
p. 929-937
|
artikel
|
| 14 |
Avelumab: First Global Approval
|
Kim, Esther S.
|
|
2017
|
|
8 |
p. 929-937
|
artikel
|
| 15 |
Azacitidine
|
Keating, Gillian M.
|
|
|
|
8 |
p. 1111-1136
|
artikel
|
| 16 |
Azacitidine
|
Keating, Gillian M.
|
|
2012
|
|
8 |
p. 1111-1136
|
artikel
|
| 17 |
Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
|
Scott, Lesley J.
|
|
2016
|
|
8 |
p. 889-900
|
artikel
|
| 18 |
Bacterial Meningitis in Children
|
Yogev, Ram
|
|
|
|
8 |
p. 1097-1112
|
artikel
|
| 19 |
Botulinum Toxin A (Dysport®)
|
Keam, Susan J.
|
|
|
|
8 |
p. 1043-1058
|
artikel
|
| 20 |
Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis
|
Hoy, Sheridan M.
|
|
2015
|
|
8 |
p. 879-886
|
artikel
|
| 21 |
Castration-Resistant Prostate Cancer
|
Lorenzo, Giuseppe Di
|
|
2010
|
|
8 |
p. 983-1000
|
artikel
|
| 22 |
Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma
|
Lee, Arnold
|
|
|
|
8 |
p. 813-819
|
artikel
|
| 23 |
Cipaglucosidase Alfa: First Approval
|
Blair, Hannah A.
|
|
|
|
8 |
p. 739-745
|
artikel
|
| 24 |
Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions
|
Lund, Marie
|
|
2017
|
|
8 |
p. 859-883
|
artikel
|
| 25 |
Colorectal Cancer: Why Does Side Matter?
|
Gallois, Claire
|
|
2018
|
|
8 |
p. 789-798
|
artikel
|
| 26 |
Combination Molecularly Targeted Drug Therapy in Metastatic Melanoma: Progress to Date
|
Lemech, Charlotte
|
|
2013
|
|
8 |
p. 767-777
|
artikel
|
| 27 |
Comment on: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
|
Pires, Antonio
|
|
2018
|
|
8 |
p. 851-852
|
artikel
|
| 28 |
Correction to: Ibalizumab: First Global Approval
|
Markham, Anthony
|
|
2018
|
|
8 |
p. 859
|
artikel
|
| 29 |
Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
|
Hoy, Sheridan M.
|
|
2018
|
|
8 |
p. 857
|
artikel
|
| 30 |
Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
|
Heo, Young-A.
|
|
2019
|
|
8 |
p. 901
|
artikel
|
| 31 |
Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer
|
Lau, Sally C. M.
|
|
2019
|
|
8 |
p. 823-831
|
artikel
|
| 32 |
Delafloxacin: A Review in Community-Acquired Pneumonia
|
Lee, Arnold
|
|
|
|
8 |
p. 913-923
|
artikel
|
| 33 |
Dinutuximab: First Global Approval
|
Dhillon, Sohita
|
|
2015
|
|
8 |
p. 923-927
|
artikel
|
| 34 |
Diquafosol Ophthalmic Solution 3 %: A Review of Its Use in Dry Eye
|
Keating, Gillian M.
|
|
2015
|
|
8 |
p. 911-922
|
artikel
|
| 35 |
Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?
|
Lenglet, Aurelie
|
|
2019
|
|
8 |
p. 855-862
|
artikel
|
| 36 |
Drug-Induced Macular Edema
|
Makri, Olga E.
|
|
2013
|
|
8 |
p. 789-802
|
artikel
|
| 37 |
Drugs in Development for Acute Kidney Injury
|
Hulse, Matthew
|
|
2019
|
|
8 |
p. 811-821
|
artikel
|
| 38 |
DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™)
|
Dhillon, Sohita
|
|
2010
|
|
8 |
p. 1021-1058
|
artikel
|
| 39 |
Elbasvir/Grazoprevir: A Review in Chronic HCV Genotypes 1 and 4
|
Al-Salama, Zaina T.
|
|
2017
|
|
8 |
p. 911-921
|
artikel
|
| 40 |
Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia
|
Burness, Celeste B.
|
|
2016
|
|
8 |
p. 869-878
|
artikel
|
| 41 |
Epidemiology and Management of Kawasaki Disease
|
Luca, Nadia J. C.
|
|
|
|
8 |
p. 1029-1038
|
artikel
|
| 42 |
Epidemiology and Management of Kawasaki Disease
|
Luca, Nadia J. C.
|
|
2012
|
|
8 |
p. 1029-1038
|
artikel
|
| 43 |
Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
|
Banerjee, Shubhasree
|
|
2017
|
|
8 |
p. 939
|
artikel
|
| 44 |
Erratum to: Management Strategies for Clopidogrel Hypersensitivity
|
Beavers, Craig J.
|
|
2016
|
|
8 |
p. 913
|
artikel
|
| 45 |
Erratum to: Panobinostat: First Global Approval
|
Garnock-Jones, Karly P.
|
|
2015
|
|
8 |
p. 929
|
artikel
|
| 46 |
Extended-Release Intramuscular Paliperidone Palmitate
|
Carter, Natalie J.
|
|
2012
|
|
8 |
p. 1137-1160
|
artikel
|
| 47 |
First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future Directions
|
González-Martín, Antonio
|
|
2014
|
|
8 |
p. 879-889
|
artikel
|
| 48 |
Fosdenopterin: First Approval
|
Kang, Connie
|
|
|
|
8 |
p. 953-956
|
artikel
|
| 49 |
Fostamatinib: A Review in Chronic Immune Thrombocytopenia
|
Paik, Julia
|
|
|
|
8 |
p. 935-943
|
artikel
|
| 50 |
Gabapentin Enacarbil: A Review in Restless Legs Syndrome
|
Kim, Esther S.
|
|
2016
|
|
8 |
p. 879-887
|
artikel
|
| 51 |
Ganaxolone: First Approval
|
Lamb, Yvette N.
|
|
|
|
8 |
p. 933-940
|
artikel
|
| 52 |
Ganciclovir
|
McGavin, Jane K.
|
|
|
|
8 |
p. 1153-1183
|
artikel
|
| 53 |
IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses
|
Roh, Youkyung S.
|
|
|
|
8 |
p. 895-905
|
artikel
|
| 54 |
Immune Globulin Subcutaneous (Human) 20%
|
McCormack, Paul L.
|
|
2012
|
|
8 |
p. 1087-1097
|
artikel
|
| 55 |
Innovation in Targeted Intra-articular Therapies for Osteoarthritis
|
Assi, Reem
|
|
|
|
8 |
p. 649-663
|
artikel
|
| 56 |
Intravenous Ibuprofen
|
Scott, Lesley J.
|
|
2012
|
|
8 |
p. 1099-1109
|
artikel
|
| 57 |
Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?
|
Updike, Wendy H.
|
|
|
|
8 |
p. 881-893
|
artikel
|
| 58 |
Istradefylline: First Global Approval
|
Dungo, Rosselle
|
|
2013
|
|
8 |
p. 875-882
|
artikel
|
| 59 |
Ixekizumab: First Global Approval
|
Markham, Anthony
|
|
2016
|
|
8 |
p. 901-905
|
artikel
|
| 60 |
Levodopa Inhalation Powder: A Review in Parkinson’s Disease
|
Paik, Julia
|
|
|
|
8 |
p. 821-828
|
artikel
|
| 61 |
Liraglutide: A Review of Its Use in the Management of Obesity
|
Scott, Lesley J.
|
|
2015
|
|
8 |
p. 899-910
|
artikel
|
| 62 |
Lithium in the Treatment of Major Depressive Disorder
|
Bschor, Tom
|
|
2014
|
|
8 |
p. 855-862
|
artikel
|
| 63 |
Luseogliflozin: First Global Approval
|
Markham, Anthony
|
|
2014
|
|
8 |
p. 945-950
|
artikel
|
| 64 |
Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia
|
Kang, Connie
|
|
|
|
8 |
p. 945-952
|
artikel
|
| 65 |
Management of Embolic Stroke of Undetermined Source (ESUS)
|
Geisler, Tobias
|
|
2018
|
|
8 |
p. 823-831
|
artikel
|
| 66 |
Management of Metastatic Castration-Resistant Prostate Cancer
|
Mukherji, Deborah
|
|
2012
|
|
8 |
p. 1011-1028
|
artikel
|
| 67 |
Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?
|
Califano, Raffaele
|
|
2016
|
|
8 |
p. 831-840
|
artikel
|
| 68 |
Matrix Metalloproteinase Inhibitors
|
Dormán, György
|
|
2010
|
|
8 |
p. 949-964
|
artikel
|
| 69 |
Medical Expulsive Therapy: Is It Time to SUSPEND Judgement?
|
Amer, Tarik
|
|
2017
|
|
8 |
p. 809-812
|
artikel
|
| 70 |
Melphalan Flufenamide (Melflufen): First Approval
|
Dhillon, Sohita
|
|
|
|
8 |
p. 963-969
|
artikel
|
| 71 |
Memantine Extended Release (28 mg Once Daily): A Review of Its Use in Alzheimer’s Disease
|
Plosker, Greg L.
|
|
2015
|
|
8 |
p. 887-897
|
artikel
|
| 72 |
Mirabegron: A Review in Overactive Bladder Syndrome
|
Deeks, Emma D.
|
|
2018
|
|
8 |
p. 833-844
|
artikel
|
| 73 |
Naldemedine: First Global Approval
|
Markham, Anthony
|
|
2017
|
|
8 |
p. 923-927
|
artikel
|
| 74 |
Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer
|
Isaacs, James
|
|
|
|
8 |
p. 855-863
|
artikel
|
| 75 |
New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation
|
Eid, Albert J.
|
|
2010
|
|
8 |
p. 965-981
|
artikel
|
| 76 |
New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation
|
Eid, Albert J.
|
|
|
|
8 |
p. 965-981
|
artikel
|
| 77 |
New Topical Therapies in Development for Atopic Dermatitis
|
Freitas, Egídio
|
|
|
|
8 |
p. 843-853
|
artikel
|
| 78 |
Next-Generation Phosphate Binders: Focus on Iron-Based Binders
|
Nastou, Dimitra
|
|
2014
|
|
8 |
p. 863-877
|
artikel
|
| 79 |
Nivolumab Plus Relatlimab: First Approval
|
Paik, Julia
|
|
|
|
8 |
p. 925-931
|
artikel
|
| 80 |
Ofatumumab
|
Sanford, Mark
|
|
2010
|
|
8 |
p. 1013-1019
|
artikel
|
| 81 |
Olipudase Alfa: First Approval
|
Keam, Susan J.
|
|
|
|
8 |
p. 941-947
|
artikel
|
| 82 |
Omaveloxolone: First Approval
|
Lee, Arnold
|
|
|
|
8 |
p. 725-729
|
artikel
|
| 83 |
Optimizing the Use of Aspirin for Cardiovascular Prevention
|
Casado-Arroyo, Rubén
|
|
2013
|
|
8 |
p. 803-814
|
artikel
|
| 84 |
Overcoming Reduced Glucocorticoid Sensitivity in Airway Disease
|
Marwick, John A.
|
|
2010
|
|
8 |
p. 929-948
|
artikel
|
| 85 |
Ozanimod: First Approval
|
Lamb, Yvette N.
|
|
|
|
8 |
p. 841-848
|
artikel
|
| 86 |
Panitumumab
|
Keating, Gillian M.
|
|
2010
|
|
8 |
p. 1059-1078
|
artikel
|
| 87 |
Peficitinib: First Global Approval
|
Markham, Anthony
|
|
2019
|
|
8 |
p. 887-891
|
artikel
|
| 88 |
Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications
|
Autmizguine, Julie
|
|
2014
|
|
8 |
p. 891-909
|
artikel
|
| 89 |
Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications
|
Autmizguine, Julie
|
|
|
|
8 |
p. 891-909
|
artikel
|
| 90 |
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
|
Nandoskar, A.
|
|
2017
|
|
8 |
p. 885-910
|
artikel
|
| 91 |
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside
|
Palandri, Chiara
|
|
|
|
8 |
p. 889-912
|
artikel
|
| 92 |
Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
|
Salam, S. N.
|
|
2016
|
|
8 |
p. 841-852
|
artikel
|
| 93 |
Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals
|
Menon, Deepak
|
|
|
|
8 |
p. 865-887
|
artikel
|
| 94 |
Ponesimod: First Approval
|
Markham, Anthony
|
|
|
|
8 |
p. 957-962
|
artikel
|
| 95 |
Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
|
Moreau, Philippe
|
|
2016
|
|
8 |
p. 853-867
|
artikel
|
| 96 |
Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma
|
Moreau, Philippe
|
|
|
|
8 |
p. 853-867
|
artikel
|
| 97 |
Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review
|
Palmeirim, Marta S.
|
|
|
|
8 |
p. 907-921
|
artikel
|
| 98 |
Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management
|
Santos, Alicia
|
|
2017
|
|
8 |
p. 829-842
|
artikel
|
| 99 |
Ravulizumab: A Review in Generalised Myasthenia Gravis
|
Kang, Connie
|
|
|
|
8 |
p. 717-723
|
artikel
|
| 100 |
Reslizumab: First Global Approval
|
Markham, Anthony
|
|
2016
|
|
8 |
p. 907-911
|
artikel
|
| 101 |
Retifanlimab: First Approval
|
Kang, Connie
|
|
|
|
8 |
p. 731-737
|
artikel
|
| 102 |
Risankizumab: First Global Approval
|
McKeage, Kate
|
|
2019
|
|
8 |
p. 893-900
|
artikel
|
| 103 |
Risperidone Long-Acting Injection
|
Deeks, Emma D.
|
|
2010
|
|
8 |
p. 1001-1012
|
artikel
|
| 104 |
Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence
|
Kate, Vikram
|
|
2013
|
|
8 |
p. 815-824
|
artikel
|
| 105 |
Sickle Cell Anaemia
|
Ballas, Samir K.
|
|
|
|
8 |
p. 1143-1172
|
artikel
|
| 106 |
S-1 (Teysuno®): A Review of Its Use in Advanced Gastric Cancer in Non-Asian Populations
|
Sanford, M.
|
|
2013
|
|
8 |
p. 845-855
|
artikel
|
| 107 |
Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy
|
Lamb, Yvette N.
|
|
2019
|
|
8 |
p. 863-874
|
artikel
|
| 108 |
Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies
|
Moreira, Jonathan
|
|
|
|
8 |
p. 843-857
|
artikel
|
| 109 |
Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies
|
Moreira, Jonathan
|
|
2017
|
|
8 |
p. 843-857
|
artikel
|
| 110 |
Targeting AMPK by Statins: A Potential Therapeutic Approach
|
Dehnavi, Sajad
|
|
|
|
8 |
p. 923-933
|
artikel
|
| 111 |
Targeting Interferons in Systemic Lupus Erythematosus: Current and Future Prospects
|
Mathian, Alexis
|
|
2015
|
|
8 |
p. 835-846
|
artikel
|
| 112 |
Targeting α-Synuclein in Parkinson’s Disease: Progress Towards the Development of Disease-Modifying Therapeutics
|
Savitt, Daniel
|
|
2019
|
|
8 |
p. 797-810
|
artikel
|
| 113 |
Tepotinib: First Approval
|
Markham, Anthony
|
|
|
|
8 |
p. 829-833
|
artikel
|
| 114 |
Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis
|
Scott, Lesley J.
|
|
2019
|
|
8 |
p. 875-886
|
artikel
|
| 115 |
The Evolution of Insulin Glargine and its Continuing Contribution to Diabetes Care
|
Hilgenfeld, Rolf
|
|
2014
|
|
8 |
p. 911-927
|
artikel
|
| 116 |
The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
|
Cives, Mauro
|
|
2015
|
|
8 |
p. 847-858
|
artikel
|
| 117 |
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
|
Alsultan, Abdullah
|
|
2014
|
|
8 |
p. 839-854
|
artikel
|
| 118 |
Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson’s Disease
|
Vijiaratnam, Nirosen
|
|
|
|
8 |
p. 775-796
|
artikel
|
| 119 |
The Role of Capecitabine in Locally Advanced Rectal Cancer Treatment
|
Fernández-Martos, Carlos
|
|
2012
|
|
8 |
p. 1057-1073
|
artikel
|
| 120 |
The Role of Vitamin D in Health and Disease: A Narrative Review on the Mechanisms Linking Vitamin D with Disease and the Effects of Supplementation
|
Rebelos, Eleni
|
|
|
|
8 |
p. 665-685
|
artikel
|
| 121 |
Tildrakizumab: First Global Approval
|
Markham, Anthony
|
|
2018
|
|
8 |
p. 845-849
|
artikel
|
| 122 |
Tirabrutinib: First Approval
|
Dhillon, Sohita
|
|
|
|
8 |
p. 835-840
|
artikel
|
| 123 |
Tofacitinib: A Review of its Use in Adult Patients with Rheumatoid Arthritis
|
Scott, Lesley J.
|
|
2013
|
|
8 |
p. 857-874
|
artikel
|
| 124 |
Tofogliflozin: First Global Approval
|
Poole, Raewyn M.
|
|
2014
|
|
8 |
p. 939-944
|
artikel
|
| 125 |
Treatment of Acne Vulgaris During Pregnancy and Lactation
|
Kong, Y. L.
|
|
2013
|
|
8 |
p. 779-787
|
artikel
|
| 126 |
Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review
|
Raffray, Loïc
|
|
2018
|
|
8 |
p. 809-821
|
artikel
|
| 127 |
Treatment of Hepatitis C in Patients with Cirrhosis: Remaining Challenges for Direct-Acting Antiviral Therapy
|
Majumdar, Avik
|
|
2015
|
|
8 |
p. 823-834
|
artikel
|
| 128 |
Treatment of Pulmonary Arterial Hypertension in Connective Tissue Disease
|
Grünig, Ekkehard
|
|
|
|
8 |
p. 1039-1056
|
artikel
|
| 129 |
Treatment of Pulmonary Arterial Hypertension in Connective Tissue Disease
|
Grünig, Ekkehard
|
|
2012
|
|
8 |
p. 1039-1056
|
artikel
|
| 130 |
Ulipristal Acetate
|
Croxtall, Jamie D.
|
|
2012
|
|
8 |
p. 1075-1085
|
artikel
|
| 131 |
Uveitis Therapy: The Corticosteroid Options
|
Valdes, Lianna M.
|
|
|
|
8 |
p. 765-773
|
artikel
|
| 132 |
Vaccines Against Genital Herpes
|
Morrison, Lynda A.
|
|
|
|
8 |
p. 1119-1129
|
artikel
|
| 133 |
Vaccines Targeting PCSK9: A Promising Alternative to Passive Immunization with Monoclonal Antibodies in the Management of Hyperlipidaemia?
|
Weisshaar, Stefan
|
|
2018
|
|
8 |
p. 799-808
|
artikel
|
Tijdschrift beschrijving